Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px
Document › Details

Clavis Pharma ASA. (1/18/12). "Press Release: Clavis Pharma. Raises NOK 163 Million in Private Placement". Oslo.

Organisations Organisation Clavis Pharma ASA
  Today Aqualis ASA
  Group Aqualis ASA
  Organisation 2 Braganza AS
Products Product elacytarabine
  Product 2 CP-4126 (CO-101)
Index term Index term Clavis Pharma–SEVERAL: investment, 201201 private placement NOK163m 2.86m new shares NOK53/share
Persons Person Hellebø, Olav (ReNeuron 201507 CEO before Clavis Pharma 201108 CEO)
  Person 2 Manum, Gunnar (Clavis Pharma 201107 CFO)
     


   
Record changed: 2015-08-10

Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px

More documents for Aqualis ASA


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px